Nalaganje...
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
Recent advances in cancer treatment have emerged from new immunotherapies targeting T-cell inhibitory receptors, including cytotoxic T-lymphocyte associated antigen (CTLA)-4 and programmed cell death (PD)-1. In this context, anti-CTLA-4 and anti-PD-1 monoclonal antibodies have demonstrated survival...
Shranjeno v:
| izdano v: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5786548/ https://ncbi.nlm.nih.gov/pubmed/29403496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00014 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|